Has Dwayne Rollins, MD received payments from drug or device companies?

Yes. Drug and device makers reported $771 in general payments to Dwayne Rollins, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dwayne Rollins, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dwayne Rollins, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dwayne Rollins, MD

Otolaryngology · Rosedale, NYNPI 1861447153

Payments from drug & device makers

$771in general payments, 2019–2025

Across 34 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$586
Optinose US, Inc.$52
Phathom Pharmaceuticals, Inc.$46
Bausch & Lomb, A Division Of Bausch Health US, LLC$38
Stryker$30
Aerin Medical Inc.$19

What the payments were for

Speaking & faculty fees$385%
Food & beverage$73395%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	27	$586
Optinose US, Inc.	2	$52
Phathom Pharmaceuticals, Inc.	2	$46
Bausch & Lomb, A Division Of Bausch Health US, LLC	1	$38
Stryker	1	$30
Aerin Medical Inc.	1	$19

How this compares

$771 in reported general payments places this provider in the 40th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York →

Medicare billing

Part B allowed, 2024

$224,209

Medicare patients

432

Services billed

2,598

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluticasone Propionate	1,201	$10,472
Azelastine Hcl	481	$7,275
Fluocinolone Acetonide Oil	111	$3,498
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort	63	$2,535
Mometasone Furoate	81	$2,512
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	20	$2,050
Olopatadine Hcl	48	$2,025
CefuroximeCefuroxime Axetil	145	$1,884
Methylprednisolone	258	$1,710
Montelukast Sodium	222	$1,379
Pantoprazole Sodium	208	$1,268
Levocetirizine Dihydrochloride	83	$721
Famotidine	108	$670
Meclizine Hcl	70	$616
Flunisolide	14	$460

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Rosedale

Robert KellmanSyracuse$2.5M
Anthony DelsignoreNew York$966K
Roheen RaithathaNew York$882K
Dennis KrausNew York$524K
Ashutosh KackerNew York$387K
Lawrence LustigNew York$383K
Brett MilesNew York$368K
Alfred Marc IloretaNew York$342K
Nora PerkinsAlbany$315K
Gavin SetzenAlbany$299K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →